Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-labelled, Investigator-initiated Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

NCT06187311 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT06187311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06187311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-labelled, Investigator-initiated Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 12, 2023
Completion date
June 30, 2027
Enrollment
940 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant adverse reaction, atrial fibrillation